Bailard Inc. Buys Shares of 38,600 Varex Imaging $VREX

Bailard Inc. purchased a new position in shares of Varex Imaging (NASDAQ:VREX) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 38,600 shares of the company’s stock, valued at approximately $479,000. Bailard Inc. owned 0.09% of Varex Imaging at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. State of Alaska Department of Revenue acquired a new stake in Varex Imaging in the third quarter worth $27,000. BNP Paribas Financial Markets boosted its holdings in shares of Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after acquiring an additional 2,036 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in shares of Varex Imaging by 25.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 13,104 shares of the company’s stock worth $115,000 after acquiring an additional 2,659 shares during the last quarter. Cerity Partners LLC acquired a new stake in shares of Varex Imaging in the 2nd quarter worth about $123,000. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after acquiring an additional 1,442 shares during the period.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Oppenheimer decreased their target price on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Wall Street Zen upgraded Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 22nd. B. Riley restated a “buy” rating and issued a $16.00 target price on shares of Varex Imaging in a research report on Wednesday, November 19th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $17.00.

Varex Imaging Price Performance

NASDAQ VREX opened at $13.85 on Friday. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $15.46. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.43 and a quick ratio of 1.83. The firm has a market capitalization of $580.59 million, a PE ratio of -8.15 and a beta of 0.86. The company’s 50 day simple moving average is $12.17 and its 200 day simple moving average is $11.18.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.19. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.The firm had revenue of $228.90 million during the quarter, compared to the consensus estimate of $219.26 million. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. As a group, equities research analysts forecast that Varex Imaging will post 0.53 EPS for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.